1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Hematology Diagnostic Tests - Medical Devices Pipeline Assessment, 2015

Hematology Diagnostic Tests - Medical Devices Pipeline Assessment, 2015

Summary

GlobalData's Medical Devices sector report, “Hematology Diagnostic Tests - Medical Devices Pipeline Assessment, 2015" provides an overview of Hematology Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hematology Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Hematology Diagnostic Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Hematology Diagnostic Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Hematology Diagnostic Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table Of Contents

Hematology Diagnostic Tests - Medical Devices Pipeline Assessment, 2015
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 18
2 Introduction 19
2.1 Hematology Diagnostic Tests Overview 19
3 Products under Development 22
3.1 Hematology Diagnostic Tests - Pipeline Products by Stage of Development 22
3.2 Hematology Diagnostic Tests - Pipeline Products by Segment 23
3.3 Hematology Diagnostic Tests - Pipeline Products by Territory 25
3.4 Hematology Diagnostic Tests - Pipeline Products by Regulatory Path 26
3.5 Hematology Diagnostic Tests - Pipeline Products by Estimated Approval Date 27
4 Hematology Diagnostic Tests - Pipeline Products under Development by Companies 28
4.1 Hematology Diagnostic Tests Companies - Pipeline Products by Stage of Development 28
4.2 Hematology Diagnostic Tests - Pipeline Products by Stage of Development 32
5 Hematology Diagnostic Tests Companies and Product Overview 40
5.1 Abbott Diagnostics Company Overview 40
5.1.1 Abbott Diagnostics Pipeline Products and Ongoing Clinical Trials Overview 40
5.2 AbSorber AB Company Overview 42
5.2.1 AbSorber AB Pipeline Products and Ongoing Clinical Trials Overview 42
5.3 Alere Inc. Company Overview 43
5.3.1 Alere Inc. Pipeline Products and Ongoing Clinical Trials Overview 43
5.4 Analyticon Biotechnologies AG Company Overview 45
5.4.1 Analyticon Biotechnologies AG Pipeline Products and Ongoing Clinical Trials Overview 45
5.5 Apollo Medical Devices LLC Company Overview 57
5.5.1 Apollo Medical Devices LLC Pipeline Products and Ongoing Clinical Trials Overview 57
5.6 Asta Fluidic Technologies, Inc. Company Overview 58
5.6.1 Asta Fluidic Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 58
5.7 Auer Precision Company Overview 59
5.7.1 Auer Precision Pipeline Products and Ongoing Clinical Trials Overview 59
5.8 Axxin Company Overview 60
5.8.1 Axxin Pipeline Products and Ongoing Clinical Trials Overview 60
5.9 Beckman Coulter, Inc. Company Overview 61
5.9.1 Beckman Coulter, Inc. Pipeline Products and Ongoing Clinical Trials Overview 61
5.10 Besst Test Company Overview 62
5.10.1 Besst Test Pipeline Products and Ongoing Clinical Trials Overview 62
5.11 BioMedica USA LLC Company Overview 63
5.11.1 BioMedica USA LLC Pipeline Products and Ongoing Clinical Trials Overview 63
5.12 BioMedomics, Inc Company Overview 65
5.12.1 BioMedomics, Inc Pipeline Products and Ongoing Clinical Trials Overview 65
5.13 BioRap Technologies Ltd. Company Overview 67
5.13.1 BioRap Technologies Ltd. Pipeline Products and Ongoing Clinical Trials Overview 67
5.14 Blaze Medical Devices Company Overview 68
5.14.1 Blaze Medical Devices Pipeline Products and Ongoing Clinical Trials Overview 68
5.15 Braun Biosystems, Inc. Company Overview 69
5.15.1 Braun Biosystems, Inc. Pipeline Products and Ongoing Clinical Trials Overview 69
5.16 Carclo Diagnostic Solutions Ltd Company Overview 70
5.16.1 Carclo Diagnostic Solutions Ltd Pipeline Products and Ongoing Clinical Trials Overview 70
5.17 Cellphire, Inc. Company Overview 71
5.17.1 Cellphire, Inc. Pipeline Products and Ongoing Clinical Trials Overview 71
5.18 Center for Translational Molecular Medicine Company Overview 72
5.18.1 Center for Translational Molecular Medicine Pipeline Products and Ongoing Clinical Trials Overview 72
5.19 Coramed Technologies, LLC Company Overview 75
5.19.1 Coramed Technologies, LLC Pipeline Products and Ongoing Clinical Trials Overview 75
5.20 CPSI Biotech Company Overview 76
5.20.1 CPSI Biotech Pipeline Products and Ongoing Clinical Trials Overview 76
5.21 CW Optics, Inc. Company Overview 77
5.21.1 CW Optics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 77
5.22 Diagnostica Stago, Inc. Company Overview 78
5.22.1 Diagnostica Stago, Inc. Pipeline Products and Ongoing Clinical Trials Overview 78
5.23 Diatron Medical Instruments Limited Company Overview 83
5.23.1 Diatron Medical Instruments Limited Pipeline Products and Ongoing Clinical Trials Overview 83
5.24 Drew Scientific Co. Limited Company Overview 84
5.24.1 Drew Scientific Co. Limited Pipeline Products and Ongoing Clinical Trials Overview 84
5.25 Entegrion, Inc. Company Overview 86
5.25.1 Entegrion, Inc. Pipeline Products and Ongoing Clinical Trials Overview 86
5.26 Haemonetics Corporation Company Overview 87
5.26.1 Haemonetics Corporation Pipeline Products and Ongoing Clinical Trials Overview 87
5.27 Helena Laboratories Corp. Company Overview 90
5.27.1 Helena Laboratories Corp. Pipeline Products and Ongoing Clinical Trials Overview 90
5.28 HemoSonics, LLC Company Overview 108
5.28.1 HemoSonics, LLC Pipeline Products and Ongoing Clinical Trials Overview 108
5.29 Hologic, Inc. Company Overview 116
5.29.1 Hologic, Inc. Pipeline Products and Ongoing Clinical Trials Overview 116
5.30 Immucor, Inc. Company Overview 118
5.30.1 Immucor, Inc. Pipeline Products and Ongoing Clinical Trials Overview 118
5.31 Immunostep S.L Company Overview 119
5.31.1 Immunostep S.L Pipeline Products and Ongoing Clinical Trials Overview 119
5.32 Innobiochips Company Overview 120
5.32.1 Innobiochips Pipeline Products and Ongoing Clinical Trials Overview 120
5.33 Instrumentation Laboratory Company Company Overview 121
5.33.1 Instrumentation Laboratory Company Pipeline Products and Ongoing Clinical Trials Overview 121
5.34 Ionu Biosystems Company Overview 137
5.34.1 Ionu Biosystems Pipeline Products and Ongoing Clinical Trials Overview 137
5.35 IRIS International, Inc. Company Overview 138
5.35.1 IRIS International, Inc. Pipeline Products and Ongoing Clinical Trials Overview 138
5.36 i-SENS, Inc. Company Overview 139
5.36.1 i-SENS, Inc. Pipeline Products and Ongoing Clinical Trials Overview 139
5.37 KeenCAT Technologies Company Overview 140
5.37.1 KeenCAT Technologies Pipeline Products and Ongoing Clinical Trials Overview 140
5.38 Laboratorios Alpha San Ignacio Pharma S.L. Company Overview 142
5.38.1 Laboratorios Alpha San Ignacio Pharma S.L. Pipeline Products and Ongoing Clinical Trials Overview 142
5.39 LightIntegra Technology Inc. Company Overview 143
5.39.1 LightIntegra Technology Inc. Pipeline Products and Ongoing Clinical Trials Overview 143
5.40 MedPrime Technologies Pvt. Ltd. Company Overview 144
5.40.1 MedPrime Technologies Pvt. Ltd. Pipeline Products and Ongoing Clinical Trials Overview 144
5.41 Mindray Medical International Limited Company Overview 145
5.41.1 Mindray Medical International Limited Pipeline Products and Ongoing Clinical Trials Overview 145
5.42 Nexus Medical, LLC Company Overview 149
5.42.1 Nexus Medical, LLC Pipeline Products and Ongoing Clinical Trials Overview 149
5.43 Noninvasix, Inc. Company Overview 150
5.43.1 Noninvasix, Inc. Pipeline Products and Ongoing Clinical Trials Overview 150
5.44 North Carolina State University Company Overview 151
5.44.1 North Carolina State University Pipeline Products and Ongoing Clinical Trials Overview 151
5.45 Novametics, Inc. Company Overview 152
5.45.1 Novametics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 152
5.46 Ohmx Corporation Company Overview 153
5.46.1 Ohmx Corporation Pipeline Products and Ongoing Clinical Trials Overview 153
5.47 Ortho-Clinical Diagnostics Inc. Company Overview 154
5.47.1 Ortho-Clinical Diagnostics Inc. Pipeline Products and Ongoing Clinical Trials Overview 154
5.48 Pakwa Technologies Company Overview 157
5.48.1 Pakwa Technologies Pipeline Products and Ongoing Clinical Trials Overview 157
5.49 PixCell Medical Technologies Ltd. Company Overview 158
5.49.1 PixCell Medical Technologies Ltd. Pipeline Products and Ongoing Clinical Trials Overview 158
5.50 PortaScience Inc. Company Overview 160
5.50.1 PortaScience Inc. Pipeline Products and Ongoing Clinical Trials Overview 160
5.51 Qloudlab SA Company Overview 161
5.51.1 Qloudlab SA Pipeline Products and Ongoing Clinical Trials Overview 161
5.52 Quotient Limited Company Overview 162
5.52.1 Quotient Limited Pipeline Products and Ongoing Clinical Trials Overview 162
5.53 Radiometer Medical ApS Company Overview 180
5.53.1 Radiometer Medical ApS Pipeline Products and Ongoing Clinical Trials Overview 180
5.54 Rapidx, Ltd. Company Overview 182
5.54.1 Rapidx, Ltd. Pipeline Products and Ongoing Clinical Trials Overview 182
5.55 Rheomics, Inc. Company Overview 183
5.55.1 Rheomics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 183
5.56 Roche Diagnostics International Ltd. Company Overview 184
5.56.1 Roche Diagnostics International Ltd. Pipeline Products and Ongoing Clinical Trials Overview 184
5.57 SATT Conectus Alsace SAS Company Overview 188
5.57.1 SATT Conectus Alsace SAS Pipeline Products and Ongoing Clinical Trials Overview 188
5.58 Sebia SA Company Overview 190
5.58.1 Sebia SA Pipeline Products and Ongoing Clinical Trials Overview 190
5.59 Sekisui Medical Co., Ltd. Company Overview 194
5.59.1 Sekisui Medical Co., Ltd. Pipeline Products and Ongoing Clinical Trials Overview 194
5.60 Sepsis Ltd Company Overview 196
5.60.1 Sepsis Ltd Pipeline Products and Ongoing Clinical Trials Overview 196
5.61 Siemens Healthcare Diagnostics Inc. Company Overview 197
5.61.1 Siemens Healthcare Diagnostics Inc. Pipeline Products and Ongoing Clinical Trials Overview 197
5.62 SonoMedix, Inc. Company Overview 210
5.62.1 SonoMedix, Inc. Pipeline Products and Ongoing Clinical Trials Overview 210
5.63 SpinChip Diagnostics AS Company Overview 211
5.63.1 SpinChip Diagnostics AS Pipeline Products and Ongoing Clinical Trials Overview 211
5.64 SQI Diagnostics Inc. Company Overview 212
5.64.1 SQI Diagnostics Inc. Pipeline Products and Ongoing Clinical Trials Overview 212
5.65 Stanford University Company Overview 214
5.65.1 Stanford University Pipeline Products and Ongoing Clinical Trials Overview 214
5.66 Sysmex Corporation Company Overview 215
5.66.1 Sysmex Corporation Pipeline Products and Ongoing Clinical Trials Overview 215
5.67 T2 Biosystems, Inc. Company Overview 219
5.67.1 T2 Biosystems, Inc. Pipeline Products and Ongoing Clinical Trials Overview 219
5.68 Tarabios Company Overview 221
5.68.1 Tarabios Pipeline Products and Ongoing Clinical Trials Overview 221
5.69 The DNA Medicine Institute Company Overview 223
5.69.1 The DNA Medicine Institute Pipeline Products and Ongoing Clinical Trials Overview 223
5.70 The University of British Columbia Company Overview 224
5.70.1 The University of British Columbia Pipeline Products and Ongoing Clinical Trials Overview 224
5.71 Thermo Fisher Scientific Inc. Company Overview 225
5.71.1 Thermo Fisher Scientific Inc. Pipeline Products and Ongoing Clinical Trials Overview 225
5.72 Transfusion and Transplantation Technologies (Inactive) Company Overview 227
5.72.1 Transfusion and Transplantation Technologies (Inactive) Pipeline Products and Ongoing Clinical Trials Overview 227
5.73 Universal Biosensors, Inc. Company Overview 236
5.73.1 Universal Biosensors, Inc. Pipeline Products and Ongoing Clinical Trials Overview 236
5.74 University of South Florida Company Overview 238
5.74.1 University of South Florida Pipeline Products and Ongoing Clinical Trials Overview 238
5.75 University of Texas Health Science Center at Houston Company Overview 239
5.75.1 University of Texas Health Science Center at Houston Pipeline Products and Ongoing Clinical Trials Overview 239
5.76 Visca Corporation Company Overview 240
5.76.1 Visca Corporation Pipeline Products and Ongoing Clinical Trials Overview 240
5.77 Washington University in St. Louis Company Overview 241
5.77.1 Washington University in St. Louis Pipeline Products and Ongoing Clinical Trials Overview 241
6 Hematology Diagnostic Tests - Recent Developments 242
7 Appendix 530
7.1 Methodology 530
7.2 About GlobalData 532
7.3 Contact Us 532
7.4 Disclaimer 533

1.1 List of Tables
Table 1: Hematology Diagnostic Tests - Pipeline Products by Stage of Development 22
Table 2: Hematology Diagnostic Tests - Pipeline Products by Segment 24
Table 3: Hematology Diagnostic Tests - Pipeline Products by Territory 25
Table 4: Hematology Diagnostic Tests - Pipeline Products by Regulatory Path 26
Table 5: Hematology Diagnostic Tests - Pipeline Products by Estimated Approval Date 27
Table 6: Hematology Diagnostic Tests Companies - Pipeline Products by Stage of Development 28
Table 7: Hematology Diagnostic Tests - Pipeline Products by Stage of Development 32
Table 8: Abbott Diagnostics Pipeline Products and Ongoing Clinical Trials Overview 40
Table 9: Next Generation Blood Screening System - Product Status 40
Table 10: Next Generation Blood Screening System - Product Description 40
Table 11: Next Generation Hematology Analyzer - Product Status 41
Table 12: Next Generation Hematology Analyzer - Product Description 41
Table 13: AbSorber AB Pipeline Products and Ongoing Clinical Trials Overview 42
Table 14: ABO Diagnostic Test - Product Status 42
Table 15: ABO Diagnostic Test - Product Description 42
Table 16: Alere Inc. Pipeline Products and Ongoing Clinical Trials Overview 43
Table 17: Afinion PT Test - Capillary Blood - Product Status 43
Table 18: Afinion PT Test - Capillary Blood - Product Description 44
Table 19: Analyticon Biotechnologies AG Pipeline Products and Ongoing Clinical Trials Overview 45
Table 20: Activated Partial Thromboplastin Time Coagulation Reagent - Product Status 46
Table 21: Activated Partial Thromboplastin Time Coagulation Reagent - Product Description 46
Table 22: Coagulyzer 1 - Product Status 46
Table 23: Coagulyzer 1 - Product Description 47
Table 24: Coagulyzer 100 - Product Status 47
Table 25: Coagulyzer 100 - Product Description 47
Table 26: Coagulyzer 2 - Product Status 48
Table 27: Coagulyzer 2 - Product Description 48
Table 28: Coagulyzer 4 - Product Status 49
Table 29: Coagulyzer 4 - Product Description 49
Table 30: Fibrinogen Lyophilisat Coagulation Kit - Product Status 50
Table 31: Fibrinogen Lyophilisat Coagulation Kit - Product Description 50
Table 32: Hemolyzer - 5 - Diff 5P - Product Status 50
Table 33: Hemolyzer - 5 - Diff 5P - Product Description 51
Table 34: Hemolyzer - 5 - Diluent - Product Status 51
Table 35: Hemolyzer - 5 - Diluent - Product Description 51
Table 36: Hemolyzer 3 - Product Status 52
Table 37: Hemolyzer 3 - Product Description 52
Table 38: Hemolyzer 5 - Product Status 52
Table 39: Hemolyzer 5 - Product Description 53
Table 40: Hemolyzer-3-Cleaner - Product Status 53
Table 41: Hemolyzer-3-Cleaner - Product Description 54
Table 42: Hemolyzer-3-Diluent - Product Status 54
Table 43: Hemolyzer-3-Diluent - Product Description 54
Table 44: Hemolyzer-3-Lyser - Product Status 55
Table 45: Hemolyzer-3-Lyser - Product Description 55
Table 46: Hemolyzer-5-Lyser - Product Status 55
Table 47: Hemolyzer-5-Lyser - Product Description 56
Table 48: Prothrombin Time Coagulation Reagent - Product Status 56
Table 49: Prothrombin Time Coagulation Reagent - Product Description 56
Table 50: Apollo Medical Devices LLC Pipeline Products and Ongoing Clinical Trials Overview 57
Table 51: Point-Of-Care Blood Analyzer - Product Status 57
Table 52: Point-Of-Care Blood Analyzer - Product Description 57
Table 53: Asta Fluidic Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 58
Table 54: Next Generation Prenatal Monitoring Device - Product Status 58
Table 55: Next Generation Prenatal Monitoring Device - Product Description 58
Table 56: Auer Precision Pipeline Products and Ongoing Clinical Trials Overview 59
Table 57: Blood Separation Microfluidic Device - Product Status 59
Table 58: Blood Separation Microfluidic Device - Product Description 59
Table 59: Axxin Pipeline Products and Ongoing Clinical Trials Overview 60
Table 60: Burnet AX-2 CD4 Test Reader - Product Status 60
Table 61: Burnet AX-2 CD4 Test Reader - Product Description 60
Table 62: Beckman Coulter, Inc. Pipeline Products and Ongoing Clinical Trials Overview 61
Table 63: ACL TOP 700 - HIT Test - Product Status 61
Table 64: ACL TOP 700 - HIT Test - Product Description 61
Table 65: Besst Test Pipeline Products and Ongoing Clinical Trials Overview 62
Table 66: Human Blood Coagulation Monitoring Device - Product Status 62
Table 67: Human Blood Coagulation Monitoring Device - Product Description 62
Table 68: BioMedica USA LLC Pipeline Products and Ongoing Clinical Trials Overview 63
Table 69: Point-of-Care Device - Blood Coagulation - Product Status 63
Table 70: Point-of-Care Device - Blood Coagulation - Product Description 63
Table 71: Portable Diagnostic System - Hemostasis - Product Status 64
Table 72: Portable Diagnostic System - Hemostasis - Product Description 64
Table 73: BioMedomics, Inc Pipeline Products and Ongoing Clinical Trials Overview 65
Table 74: Point of Care Test - Hemoglobin F - Product Status 65
Table 75: Point of Care Test - Hemoglobin F - Product Description 65
Table 76: Point of Care Test - Hemoglobin S - Product Status 66
Table 77: Point of Care Test - Hemoglobin S - Product Description 66
Table 78: BioRap Technologies Ltd. Pipeline Products and Ongoing Clinical Trials Overview 67
Table 79: Diagnostic Kit - Coagulation - Product Status 67
Table 80: Diagnostic Kit - Coagulation - Product Description 67
Table 81: Blaze Medical Devices Pipeline Products and Ongoing Clinical Trials Overview 68
Table 82: Fragility Test - Product Status 68
Table 83: Fragility Test - Product Description 68
Table 84: Braun Biosystems, Inc. Pipeline Products and Ongoing Clinical Trials Overview 69
Table 85: Bio6 - Product Status 69
Table 86: Bio6 - Product Description 69
Table 87: Carclo Diagnostic Solutions Ltd Pipeline Products and Ongoing Clinical Trials Overview 70
Table 88: Micropoc-Lite - Product Status 70
Table 89: Micropoc-Lite - Product Description 70
Table 90: Cellphire, Inc. Pipeline Products and Ongoing Clinical Trials Overview 71
Table 91: Thrombogent - Product Status 71
Table 92: Thrombogent - Product Description 71
Table 93: Center for Translational Molecular Medicine Pipeline Products and Ongoing Clinical Trials Overview 72
Table 94: Acute Marker Assay - Product Status 72
Table 95: Acute Marker Assay - Product Description 72
Table 96: Blood Capacity Assay - Product Status 73
Table 97: Blood Capacity Assay - Product Description 73
Table 98: Diagnostic Assay Device - Product Status 73
Table 99: Diagnostic Assay Device - Product Description 74
Table 100: Diagnostic Test - Arterial Thrombosis - Product Status 74
Table 101: Diagnostic Test - Arterial Thrombosis - Product Description 74
Table 102: Coramed Technologies, LLC Pipeline Products and Ongoing Clinical Trials Overview 75
Table 103: TEG 6000 Thrombelastograph - Product Status 75
Table 104: TEG 6000 Thrombelastograph - Product Description 75
Table 105: CPSI Biotech Pipeline Products and Ongoing Clinical Trials Overview 76
Table 106: FACSGuard - Product Status 76
Table 107: FACSGuard - Product Description 76
Table 108: CW Optics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 77
Table 109: Optical Sensor - Product Status 77
Table 110: Optical Sensor - Product Description 77
Table 111: Diagnostica Stago, Inc. Pipeline Products and Ongoing Clinical Trials Overview 78
Table 112: Calibrated Automated Thrombogram - Thrombin Assay - Product Status 78
Table 113: Calibrated Automated Thrombogram - Thrombin Assay - Product Description 79
Table 114: STA Compact Max - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa - Product Status 79
Table 115: STA Compact Max - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa - Product Description 79
Table 116: STA-R Evolution Expert - Automated Ecarin Chromogenic Assay - Product Status 80
Table 117: STA-R Evolution Expert - Automated Ecarin Chromogenic Assay - Product Description 80
Table 118: STA-R Evolution Expert - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa - Product Status 80
Table 119: STA-R Evolution Expert - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa - Product Description 81
Table 120: STA-R Evolution Plus - Automated Ecarin Chromogenic Assay - Product Status 81
Table 121: STA-R Evolution Plus - Automated Ecarin Chromogenic Assay - Product Description 81
Table 122: STA-R Evolution Plus - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa - Product Status 82
Table 123: STA-R Evolution Plus - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa - Product Description 82
Table 124: Diatron Medical Instruments Limited Pipeline Products and Ongoing Clinical Trials Overview 83
Table 125: 3-part Differential Hematology Analyzer - Product Status 83

1.2 List of Figures
Figure 1: Hematology Diagnostic Tests - Pipeline Products by Stage of Development 22
Figure 2: Hematology Diagnostic Tests - Pipeline Products by Segment 23
Figure 3: Hematology Diagnostic Tests - Pipeline Products by Territory 25
Figure 4: Hematology Diagnostic Tests - Pipeline Products by Regulatory Path 26
Figure 5: Hematology Diagnostic Tests - Pipeline Products by Estimated Approval Date 27

Companies mentioned
Abbott Diagnostics
AbSorber AB
Alere Inc.
Analyticon Biotechnologies AG
Apollo Medical Devices LLC
Asta Fluidic Technologies, Inc.
Auer Precision
Axxin
Beckman Coulter, Inc.
Besst Test
BioMedica USA LLC
BioMedomics, Inc
BioRap Technologies Ltd.
Blaze Medical Devices
Braun Biosystems, Inc.
Carclo Diagnostic Solutions Ltd
Cellphire, Inc.
Center for Translational Molecular Medicine
Coramed Technologies, LLC
CPSI Biotech
CW Optics, Inc.
Diagnostica Stago, Inc.
Diatron Medical Instruments Limited
Drew Scientific Co. Limited
Entegrion, Inc.
Haemonetics Corporation
Helena Laboratories Corp.
HemoSonics, LLC
Hologic, Inc.
Immucor, Inc.
Immunostep S.L
Innobiochips
Instrumentation Laboratory Company
Ionu Biosystems
IRIS International, Inc.
i-SENS, Inc.
KeenCAT Technologies
Laboratorios Alpha San Ignacio Pharma S.L.
LightIntegra Technology Inc.
MedPrime Technologies Pvt. Ltd.
Mindray Medical International Limited
Nexus Medical, LLC
Noninvasix, Inc.
North Carolina State University
Novametics, Inc.
Ohmx Corporation
Ortho-Clinical Diagnostics Inc.
Pakwa Technologies
PixCell Medical Technologies Ltd.
PortaScience Inc.
Qloudlab SA
Quotient Limited
Radiometer Medical ApS
Rapidx, Ltd.
Rheomics, Inc.
Roche Diagnostics International Ltd.
SATT Conectus Alsace SAS
Sebia SA
Sekisui Medical Co., Ltd.
Sepsis Ltd
Siemens Healthcare Diagnostics Inc.
SonoMedix, Inc.
SpinChip Diagnostics AS
SQI Diagnostics Inc.
Stanford University
Sysmex Corporation
T2 Biosystems, Inc.
Tarabios
The DNA Medicine Institute
The University of British Columbia
Thermo Fisher Scientific Inc.
Transfusion and Transplantation Technologies
Universal Biosensors, Inc.
University of South Florida
University of Texas Health Science Center at Houston
Visca Corporation
Washington University in St. Louis

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.